help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fardella, C. E.
Right arrow Articles by Miller, W. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fardella, C. E.
Right arrow Articles by Miller, W. L.

Journal of Clinical Endocrinology & Metabolism, Vol 81, 4347-4351, Copyright © 1996 by Endocrine Society


ARTICLES

Genetic variation in P450c11AS in Chilean patients with low renin hypertension

CE Fardella, H Rodriguez, J Montero, G Zhang, P Vignolo, A Rojas, L Villarroel and WL Miller
Department of Pediatrics, University of California, San Francisco 94143, USA.

Low renin hypertension (LRH), which accounts for 10-20% of patients with idiopathic "essential" hypertension, bears hormonal similarities to mineralocorticoid-induced hypertension, but elevated mineralocorticoid concentrations have not been found. Some patients with LRH have normal, rather than suppressed, plasma aldosterone concentrations, so that the ratio of aldosterone concentration to PRA (Aldo/PRA) is high, suggesting inappropriately increased aldosterone biosynthesis. We characterized the CYP11B2 gene that encodes the aldosterone synthase, P450c11AS, in hypertensive and control populations in a single clinic in Santiago, Chile. We directly sequenced the entire CYP11B2 gene in 12 patients with LRH, 2 high renin hypertensive controls, and 2 normotensive controls. All sequences were identical, except that 8 of 24 LRH alleles encoded arginine rather than lysine at position 173. The Arg173 and Lys173 variants were expressed in transfected MA-10 cells, and their ability to convert deoxycorticosterone to aldosterone was measured; the apparent Michaelis constant (Km) for Lys173 was 2.73 mumol/L; the Km for Arg173 was 2.53 mumol/L. The apparent maximal velocity (Vmax) for Lys173 was 6.5 x 10(- 3) micrograms/mL.24 h; the Vmax for Arg173 was 7.8 x 10(-3) micrograms/mL.24 h. The first order rate constant, Vmax/Km was 2.38 for Lys173 and 3.08 for Arg173. As these values were not significantly different, we sought to determine whether Arg173 is a polymorphism linked to LRH. We examined position 173 in 52 unselected patients with idiopathic hypertension and 55 normotensive controls by PCR amplification of CYP11B2 exons 3-5 followed by digestion with Bsu361, which digests the Arg173 sequence, but not the Lys173 sequence. More of the hypertensive alleles (39 of 104, 37.5%) than normotensive alleles (25 of 110, 22.5%) carried Arg173 (chi 2 = 5.57; P < 0.02). Most of the Arg173 alleles (31 of 72, 43.1%) were from hypertensive patients with Aldo/PRA below 30, whereas only 5 of 24 (20.8%) Arg173 alleles were found in patients with Aldo/PRA greater than 30 (chi 2 = 3.79; P = 0.05) Thus, the ARg173 variant of CYP11B2 may be linked to LRH in Chilean patients.


This article has been cited by other articles:


Home page
Endocr. Rev.Home page
J. M. C. Connell, S. M. MacKenzie, E. M. Freel, R. Fraser, and E. Davies
A Lifetime of Aldosterone Excess: Long-Term Consequences of Altered Regulation of Aldosterone Production for Cardiovascular Function
Endocr. Rev., April 1, 2008; 29(2): 133 - 154.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
N. Makhanova, J. Hagaman, H.-S. Kim, and O. Smithies
Salt-Sensitive Blood Pressure in Mice With Increased Expression of Aldosterone Synthase
Hypertension, January 1, 2008; 51(1): 134 - 140.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. K. Arnett, A. E. Baird, R. A. Barkley, C. T. Basson, E. Boerwinkle, S. K. Ganesh, D. M. Herrington, Y. Hong, C. Jaquish, D. A. McDermott, et al.
Relevance of Genetics and Genomics for Prevention and Treatment of Cardiovascular Disease: A Scientific Statement From the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group
Circulation, June 5, 2007; 115(22): 2878 - 2901.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Imrie, M. Freel, B. M. Mayosi, E. Davies, R. Fraser, M. Ingram, H. J. Cordell, M. Farrall, P. J. Avery, H. Watkins, et al.
Association between Aldosterone Production and Variation in the 11{beta}-Hydroxylase (CYP11B1) Gene
J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 5051 - 5056.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
N. Makhanova, M. L.S. Sequeira-Lopez, R. A. Gomez, H.-S. Kim, and O. Smithies
Disturbed Homeostasis in Sodium-Restricted Mice Heterozygous and Homozygous for Aldosterone Synthase Gene Disruption
Hypertension, December 1, 2006; 48(6): 1151 - 1159.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Tanahashi, T. Mune, Y. Takahashi, M. Isaji, T. Suwa, H. Morita, N. Yamakita, K. Yasuda, T. Deguchi, P. C. White, et al.
Association of Lys173Arg Polymorphism with CYP11B2 Expression in Normal Adrenal Glands and Aldosterone-Producing Adenomas
J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6226 - 6231.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. C. White and W. E. Rainey
Polymorphisms in CYP11B Genes and 11-Hydroxylase Activity
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1252 - 1255.
[Full Text] [PDF]


Home page
HypertensionHome page
N. D.L. Fisher, S. Hurwitz, X. Jeunemaitre, P. N. Hopkins, N. K. Hollenberg, and G. H. Williams
Familial Aggregation of Low-Renin Hypertension
Hypertension, April 1, 2002; 39(4): 914 - 918.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. M. Kayes-Wandover, G. M. Tannin, D. Shulman, D. Peled, K. L. Jones, L. Karaviti, and P. C. White
Congenital Hyperreninemic Hypoaldosteronism Unlinked to the Aldosterone Synthase (CYP11B2) Gene
J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5379 - 5382.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Ranade, K. D. Wu, N. Risch, M. Olivier, D. Pei, C.-F. Hsiao, L.-M. Chuang, L.-T. Ho, E. Jorgenson, R. Pesich, et al.
Genetic variation in aldosterone synthase predicts plasma glucose levels
PNAS, October 25, 2001; (2001) 221467098.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S.-J. Shi, H. T. Nguyen, G. D. Sharma, L. G. Navar, and K. N. Pandey
Genetic disruption of atrial natriuretic peptide receptor-A alters renin and angiotensin II levels
Am J Physiol Renal Physiol, October 1, 2001; 281(4): F665 - F673.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. H. El-Gharbawy, V. S. Nadig, J. M. Kotchen, C. E. Grim, K. B. Sagar, M. Kaldunski, P. Hamet, Z. Pausova, D. Gaudet, F. Gossard, et al.
Arterial Pressure, Left Ventricular Mass, and Aldosterone in Essential Hypertension
Hypertension, March 1, 2001; 37(3): 845 - 850.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
A. R Lafferty, D. J Torpy, M. Stowasser, S. E Taymans, J. P. Lin, P. Huggard, R. D Gordon, and C. A Stratakis
A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22)
J. Med. Genet., November 1, 2000; 37(11): 831 - 835.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
C. E. Fardella, L. Mosso, C. Gómez-Sánchez, P. Cortés, J. Soto, L. Gómez, M. Pinto, A. Huete, E. Oestreicher, A. Foradori, et al.
Primary Hyperaldosteronism in Essential Hypertensives: Prevalence, Biochemical Profile, and Molecular Biology
J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1863 - 1867.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Fisher, R. Fraser, J. MC Connell, and E. Davies
Amino Acid Residue 147 of Human Aldosterone Synthase and 11{beta}-Hydroxylase Plays a Key Role in 11{beta}-Hydroxylation
J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1261 - 1266.
[Abstract] [Full Text]


Home page
HypertensionHome page
P. Mulatero, D. Schiavone, F. Fallo, F. Rabbia, C. Pilon, L. Chiandussi, L. Pascoe, and F. Veglio
CYP11B2 Gene Polymorphisms in Idiopathic Hyperaldosteronism
Hypertension, March 1, 2000; 35(3): 694 - 698.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
I. Komiya, T. Yamada, M. Takara, T. Asawa, M. Shimabukuro, T. Nishimori, and N. Takasu
Lys173Arg and -344T/C Variants of CYP11B2 in Japanese Patients With Low-Renin Hypertension
Hypertension, March 1, 2000; 35(3): 699 - 703.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. Takeda, K. Furukawa, S. Inaba, I. Miyamori, and H. Mabuchi
Genetic Analysis of Aldosterone Synthase in Patients with Idiopathic Hyperaldosteronism
J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1633 - 1637.
[Abstract] [Full Text]


Home page
HypertensionHome page
S. Tamaki, N. Iwai, Y. Tsujita, and M. Kinoshita
Genetic Polymorphism of CYP11B2 Gene and Hypertension in Japanese
Hypertension, January 1, 1999; 33(1): 266 - 270.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Ranade, K. D. Wu, N. Risch, M. Olivier, D. Pei, C.-F. Hsiao, L.-M. Chuang, L.-T. Ho, E. Jorgenson, R. Pesich, et al.
Genetic variation in aldosterone synthase predicts plasma glucose levels
PNAS, November 6, 2001; 98(23): 13219 - 13224.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society